Related Experiment Video
Updated: Jul 4, 2026

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
Published on: June 20, 2025
Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?
Konstantinos Tziomalos1, Vasilios G Athyros, Asterios Karagiannis
1University College London, Royal Free University College Medical School, Royal Free Hospital, Department of Clinical Biochemistry, Pond Street, London NW3 2QG, UK.
Insights
Aortic stenosis shares risk factors with atherosclerosis. Statins may slow aortic stenosis progression, but more research is needed for targeted prevention strategies.
Area of Science:
- Cardiology
- Vascular Biology
- Epidemiology
Background:
- Aortic stenosis (AS) is the most prevalent valvular heart disease globally.
- AS, aortic valve sclerosis (AVS), and aortic valve calcification (AVC) share pathogenic mechanisms with atherosclerosis.
- These conditions may indicate preclinical vascular disease.
Purpose of the Study:
- To examine the role of vascular risk factors in AS development.
- To evaluate pharmacological interventions for modifying AS progression.
Main Methods:
- Review of epidemiological data linking AS and atherosclerosis.
- Analysis of studies on vasculoprotective agents in AS patients.
Main Results:
- Common risk factors identified between AS and atherosclerosis.
- Statins show potential in delaying AS progression.
Conclusions:
- AS, AVS, and AVC are linked to atherosclerosis and may signal preclinical vascular disease.
- Statins may slow AS progression, but further studies are required.
- Future research may focus on targeted AS prevention.
Background:
Aortic stenosis (AS) is the commonest valvular heart disease in the developed world. It is becoming increasingly accepted that the pathogenesis of AS and of its preceding abnormalities, aortic valve sclerosis (AVS) and aortic valve calcification (AVC), shares many characteristics with the atherosclerotic process.
Objective:
To assess the contribution of established and emerging vascular risk factors in the development of AS and to evaluate the potential of pharmacological intervention to modify the natural history of AS.
Methods:
We reviewed the epidemiological data that link AS and atherosclerosis and studies of vasculoprotective agents in patients with AS.
Results/Conclusions:
AS, AVS and AVC share many common risk factors with atherosclerosis and are possible markers of preclinical vascular disease. Statins appear to delay the progression of AS. However, more studies are needed before introducing such pharmacologic treatment for AS. The future may point towards targeted prevention of AS.
Related Concept Videos
Aneurysm III: Interprofessional Care
Coronary Artery Disease I: Introduction
Aortic Regurgitation I: Introduction
Atherosclerosis IV: Nursing Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm I: Introduction